News & Updates

Show Multimedia Only
In utero exposure to flu spells increased risk of childhood seizures
In utero exposure to flu spells increased risk of childhood seizures
03 Oct 2024 byJairia Dela Cruz

Infants born to mothers who contracted influenza infection during pregnancy are at heightened risk of seizures, particularly febrile seizures, during childhood, according to a large study.

In utero exposure to flu spells increased risk of childhood seizures
03 Oct 2024
Can neurologic manifestations predict poor outcomes in young SARS-CoV-2, MIS-C patients?
Can neurologic manifestations predict poor outcomes in young SARS-CoV-2, MIS-C patients?
03 Oct 2024 byAudrey Abella

A prospective cohort study has shown that in patients aged <18 years hospitalized for acute SARS-CoV-2-related multisystem inflammatory syndrome in children (MIS-C), neurologic manifestations during the infection are common and may predispose them more to new neurocognitive or functional morbidity at discharge.

Can neurologic manifestations predict poor outcomes in young SARS-CoV-2, MIS-C patients?
03 Oct 2024
Is it safe to use pyrazinamide in older patients with TB?
Is it safe to use pyrazinamide in older patients with TB?
01 Oct 2024 byStephen Padilla

Adding pyrazinamide (PZA) to the initial tuberculosis (TB) treatment in older patients may lead to an increase in the incidence of adverse events (AEs), particularly allergic reactions, but not in-hospital mortality, length of hospital stay, or hepatotoxicity, reports a study, which used data from the Japanese Diagnosis Procedure Combination inpatient database.

Is it safe to use pyrazinamide in older patients with TB?
01 Oct 2024
Autism risk in children not heightened by COVID-19 pandemic exposure
Autism risk in children not heightened by COVID-19 pandemic exposure
29 Sep 2024 byJairia Dela Cruz

Children born during the COVID-19 pandemic or to mothers with history of prenatal SARS-CoV-2 infection are not at increased risk of autism compared with their counterparts who were born before the pandemic or have no exposure to maternal SARS-CoV-2 infection, as reported in a cohort study.

Autism risk in children not heightened by COVID-19 pandemic exposure
29 Sep 2024
Long-term bulevirtide use safe, efficacious in chronic HDV
Long-term bulevirtide use safe, efficacious in chronic HDV
29 Sep 2024 byStephen Padilla

Longer treatment with bulevirtide (BLV) monotherapy in patients with chronic hepatitis delta (CHD) for 96 weeks results in sustained or continued improvements in virologic, biochemical, and combined responses, a study has shown.

Long-term bulevirtide use safe, efficacious in chronic HDV
29 Sep 2024
Large UK study underpins role of COVID-19 vax in mental illness
Large UK study underpins role of COVID-19 vax in mental illness
27 Sep 2024